Respiratory Medicine and Research

Papers
(The TQCC of Respiratory Medicine and Research is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Evaluating the correspondence between the EQ-5D-5L and disease severity and quality of life in adults and adolescents with cystic fibrosis13
Editorial board10
BAP-1 IN THE DIAGNOSIS OF MALIGNANT PLEURAL MESOTHELIOMA10
Efficacy of the combination of baricitinib, remdesivir, and dexamethasone in hypoxic adults with COVID-19: A retrospective study9
French guidelines for the treatment of cancer-associated venous thromboembolism - 2023 update9
Epidemiology of interstitial lung diseases in a native Afro-Caribbean population of French West Indies8
Long-term survival comparison between the first and second waves among 265 critical COVID-19 patients admitted to the ICU: A retrospective cohort study7
An underrecognized phenotype of pulmonary emphysema with marked pulmonary gas exchange but with mild or moderate airway obstruction7
Different pathways to lung cancer diagnosis in a real-life setting7
Letter to Hitomi Tomohara-Ichishima et al6
Invited editorial: Q and A on hereditary lung cancer6
Anti-synthetase syndrome: A focus on interstitial lung disease as a diagnostic criteria6
Impact of Remdesivir on long-term outcomes in lung transplant recipients with SARS-CoV-2 infection: a retrospective cohort analysis6
Amyotrophic lateral sclerosis: A pragmatic update on recommendations for respiratory care5
Endobronchial valve (EBV) insertion for severe emphysema does not improve skeletal muscle mass or function: A pilot study on 19 patients5
Endobronchial ultrasound-guided transbronchial needle injection of cisplatin results in dynamic changes in the tumor immune microenvironment5
Impact of pulmonary hypertension on lung cancer management5
The pandemic effect: The outlook of lung transplantation5
Pulmonary Arterial Hypertension-approved drugs in Pulmonary Hypertension associated with COPD: A systematic literature review5
Diaphragm dysfunction evaluated by electroneuromyography in patients with interstitial lung disease (ILD), risks factors and impact on mortality: a retrospective observational study5
Use of complementary medicines and self-medication practices in cystic fibrosis – MUCAUTOMED study5
Sarcoidosis-like disease probably induced by apremilast: A case report5
Mid-term pulmonary sequelae after hospitalisation for COVID-19: The French SISCOVID cohort5
Association of forced oscillation technique measurements with respiratory system compliance and resistance in a 2-compartment physical model4
Comparative study of the two diagnostic criteria for idiopathic pleuroparenchymal fibroelastosis4
Immunoglobulins as a treatment modality for corticosteroid-refractory pemetrexed-induced interstitial lung disease, case report4
18F-FDG uptake by respiratory muscles in acute respiratory insufficiency in a patient with graft versus host disease4
Psychiatric disorders and long COVID4
Clinical and molecular analysis of lung cancers associated with fibrosing interstitial lung disease3
Pulmonary arterial stiffness as the main correlate of effective arterial elastance in pre- and post-capillary pulmonary hypertension3
Comparison of amikacin lung delivery between AKITA® and eFlow rapid® nebulizers in healthy controls and patients with CF: A randomized cross-over trial3
Update of guidelines for management of Community Acquired pneumonia in adults by the French Infectious Disease Society (SPILF) and the French-Speaking Society of Respiratory Diseases (SPLF)3
Real-world comparison of chemo-immunotherapy and chemotherapy alone in the treatment of extensive-stage small-cell lung cancer3
Education and implementation of home spirometry in an adolescent cystic fibrosis population3
Particle size distribution of viable nebulized bacteriophage for the treatment of multi-drug resistant Pseudomonas aeruginosa3
Pulmonary ultrasound versus chest radiography in the diagnosis of community-acquired pneumonia in adults: an updated systematic review and meta-analysis3
Sarcoid-like reaction related to ALK-ROS inhibitors in lung cancer patients3
Molecular profiling of patients with advanced lung adenocarcinoma diagnosed between 2015 and 2020 in French Polynesia3
Understanding participation challenges in lung cancer screening program: Findings from the DEP’KP80 trial in France3
Peripheral cellular biomarkers in bronchiectasis3
Exercise testing and counselling within the cystic fibrosis centres in France: A national survey3
Pulmonary adverse events of breast silicone implants and silicone injection3
Lung ultrasound and community-acquired pneumonia: from complementary tool to clinical game-changer3
Study design and rationale for IFCT- 2203 TAXIO: A study that aims to evaluate the effectiveness of a first-line chemotherapy regimen without etoposide, combined with durvalumab, for patients with ext3
Pulmonary arterial hypertension and COVID-19: Piecing the puzzle3
Evolving paradigms in pulmonary hypertension: Highlights of the 6th French Pulmonary Hypertension Network Meeting3
Hemodynamic characteristics in patients with pulmonary hypertension and chronic obstructive pulmonary disease: A retrospective monocentric cohort study3
Impact of sarcopenia defined by carina-level skeletal muscle mass on the long-term prognosis of patients with idiopathic pulmonary fibrosis2
Increasing sleep apnoea burden in the elderly in Finland from 1996 to 2018: A national registry study2
Editorial board2
Outcomes of cannabis smoking in patients with lung cancer: findings from KBP-CPHG-20202
Characteristics of airway resistance in obstructive sleep apnea patients with asthma on oscillometry2
Objective structured clinical examinations (OSCEs) for students’ training and assessment in the French respiratory medicine departments in 2021: An overview2
Real-world management of unresectable stage III non-small-cell lung cancer: Impact of durvalumab consolidation therapy in French clinical practice2
Reply to Gille and collaborators: DM and VC impairment after COVID-12
Cryobiopsy and dye marking guided by electromagnetic navigation bronchoscopy before resection of pulmonary nodule2
Corrigendum to “Particle size distribution of viable nebulized bacteriophage for the treatment of multi-drug resistant Pseudomonas aeruginosa” [Respiratory Medicine and Research 86 (2024) 101133]2
Fast pleurodesis combining talc poudrage and indwelling pleural catheter for the management of recurrent malignant pleural effusions2
Sarcoidosis Diagnostic Score (SDS) system: Impact of race, sex, organ involvement and duration of symptoms prior to diagnosis2
Thanks to the reviewers2
Awake prone position in patients with acute hypoxic respiratory failure: A narrative review2
Physical activity and sedentary behaviour in patients admitted with COPD: Associated factors2
Long-term clinical course of patients with pleuroparenchymal fibroelastosis treated with noninvasive positive pressure ventilation2
Cancer-associated thrombosis: How many patients seen in clinical practice would be eligible for a direct oral anticoagulant randomized controlled trial?2
Association between persistent dyspnea and psychological distress in COVID-19 survivors. A cross-sectional evaluation at 11 months after hospitalization2
The impact of deep venous thrombosis on 90 day mortality in chronic obstructive pulmonary disease patients presenting with pulmonary embolism2
Behaviour change interventions for physical activity in adults with chronic obstructive pulmonary disease; A systematic review and meta-analysis2
PDL1-status predicts primary resistance of metastatic, EGFR-mutated non small cell lung cancers to EGFR tyrosine-kinase inhibitors2
SPLF/SMFU/SRLF/SFAR/SFCTCV Guidelines for the management of patients with primary spontaneous pneumothorax2
The incidence of pleural infections in Finland2
Addressing the inequities in interstitial lung disease care outside specialised centres in Australia2
Evidence and unresolved questions in pulmonary hypertension: Insights from the 5th French Pulmonary Hypertension Network Meeting2
Constraints to the initiation of home non-invasive ventilation and short-term efficacy in different diagnostic groups (as a prelude to an ambulatory shift)1
Broncho-esophageal fistula: When surgery and endoscopy fail, consider physiological lung exclusion1
Pulmonary hypertension in patients with chronic obstructive pulmonary disease: Impact of lung hyperinflation on the response to pulmonary hypertension treatment1
Safety of non-cuffed tunneled central venous catheters in adults with cystic fibrosis1
Should segmentectomy indications be extended to NSCLC smaller than 3 cm without lymph node involvement? A retrospective single-center study1
Cuff-induced tracheal “aneurysm”1
Fibrotic-like abnormalities notably prevalent one year after hospitalization with COVID-191
Long-acting muscarinic antagonist versus leukotriene receptor antagonist as additional treatment in uncontrolled asthma patients used inhaled corticosteroids and long-acting β2 adrenergic agonist: a r1
Profiles, diagnostic process, and patterns of care of patients with stage III non-small cell lung cancer: A French national study1
Editorial board1
Impact of preexisting interstitial lung disease on outcomes of lung cancer surgery: A monocentric retrospective study1
Epidemiological disparities in pulmonary sarcoidosis between public and private healthcare sectors in haute-Garonne department (France)1
Dupilumab-induced rhinitis in severe asthma patients: A case series1
Titanium dental implants-related acute pneumonitis1
The intermittent intrapulmonary deflation technique for airway clearance in patients with cystic fibrosis: A randomized trial1
An exposed/unexposed cohort study assessing the effectiveness, the safety and the survival of patients established on home non-invasive ventilation after 80 years old1
Phenotypes and prognosis of systemic sclerosis: A cluster analysis1
Screening for impaired pulmonary function using peak expiratory flow: Performance of different interpretation strategies1
Increased delays of care during the COVID-19 pandemic: experience of a Lung Cancer Rapid Diagnostic Center1
Concomitant ALK translocation and EGFR C797S mutation as resistance mechanisms to osimertinib in an EGFR-mutant NSCLC patient1
Impact of SARS-CoV-2 Omicron and Delta variants in patients requiring intensive care unit (ICU) admission for COVID-19, Northern Italy, December 2021 to January 20221
Awake endoscopic (esophageal) ultrasound using the endobronchial scope (EUS-B) for patients with high risk for sedation1
Characteristics, management, and healthcare resources of patients with advanced non–small-cell lung cancer surviving 5 years after nivolumab treatment initiation: A national database analysis1
Severe respiratory syncytial virus infection in older adults – burden, clinical outcomes and implications for care1
French practical guidelines for the diagnosis and management of idiopathic pulmonary fibrosis – 2021 update. Full-length version1
Very long-term survival of a bronchial adenoid cystic-carcinoma treated bronchoscopically1
Changes in body weight reflect disease progression in pleuroparenchymal fibroelastosis1
Eligibility to lung cancer screening among staffs of a university hospital: A large cross-sectional survey1
Evaluation of reported medical services provided to pediatric viral bronchiolitis diagnoses during the COVID-19 pandemic1
Does occupational exposure affect the surgical management of patients with non-small cell lung cancer? A single-center retrospective experience1
Impact of the COVID-19 pandemic on lung transplant patients and on a cohort of patients with rare lung disease: A single-center study1
Fungal colonization and infections in patients with COVID-19 in intensive care units: A real-life experience at a tertiary-care hospital1
Comparison of two pregnancies with and without elexacaftor-tezacaftor-ivacaftor in a woman with cystic fibrosis1
Does size matter: Diagnostic yield and significance of small intrathoracic lymph nodes sampled on EBUS-TBNA1
Evaluation of efficacy and safety of rituximab in patients with progressive interstitial lung disease (ILD) with inflammatory component (EvER-ILD2): A multicentre double-blind placebo-controlled rando1
Tolerance's improvement of flexible bronchoscopy by Ericksonian hypnosis: The BREATH study1
Does pre-existing respiratory disease affect 3-month outcome following COVID hospitalisation across 4 waves: A prospective cohort analysis1
Dysbiosis and leaky gut in hyper-inflated COPD patients: Have smoking and exercise training any role?1
Effectiveness of a home-based pulmonary rehabilitation programme in people recovering from a severe and critically COVID-19 infection1
Assessing the effectiveness of inhalation therapy in patients with chronic airway diseases: A new digital measurement1
Treatment patterns and clinical outcomes of extensive stage small cell lung cancer (SCLC) in the real-world evidence ESME cohort before the era of immunotherapy1
Classification of systemic lupus erythematosus in patients with interstitial pneumonia with autoimmune features using two different sets of criteria1
Letter to Sarah Basin et al.1
Flow-mediated dilation as a marker of endothelial dysfunction in pulmonary diseases: A narrative review1
Efficacy of bronchial thermoplasty in patients with severe asthma and frequent severe exacerbations: A randomized controlled study✰1
Temporal evolution of diaphragm thickness and diaphragm excursion among subjects hospitalized with COVID-19: A prospective observational study1
Rapid and extensive calcification of pulmonary arteries1
Acute effects of fan therapy on exercise-induced breathlessness in healthy adults and people living with chronic respiratory disease: A systematic review1
Efficacy of convalescent plasma for the treatment of COVID-19 in lung transplant recipients: A multicenter French study1
Home NIV treatment quality in patients with chronic respiratory failure having participated to the French nationwide telemonitoring experimental program (The TELVENT study)1
Disease stage-related survival in idiopathic pulmonary fibrosis patients treated with nintedanib and pirfenidone: An exploratory study1
Effect of exercise-based pulmonary rehabilitation in patients with bronchiectasis: A meta-analysis1
Preoperative DLCO predicts severe early complications after liver transplantation1
Relationship of body mass index on activities of daily living in hospitalized patients with chronic obstructive pulmonary disease1
The functional consequences in severe and critical covid-19 survivors – A pilot study1
Long-term effect of tocilizumab on mortality, readmissions, persistent symptoms and lung function in SARS-CoV-2 patients 1 year after hospital discharge: A matched cohort study1
Real-life evaluation of NIV to CPAP switch in patients with chronic respiratory failure. A case control study1
Editorial board1
A 52-year-old immunocompromised man with an unusual cause of infectious lung cavitary inducing acute respiratory failure1
Malignant solitary fibrous tumor of the pleura: A narrative review of clinical characteristics, diagnosis and therapeutic options1
Acute hemodynamic response to inhaled treprostinil in pulmonary hypertension associated with interstitial lung disease: a case highlighting unresolved questions1
Progressive course of anti-nuclear matrix protein-2 (NXP-2) positive-interstitial lung disease1
Effect of elexacaftor-tezacaftor-ivacaftor on lipid parameters in adults with cystic fibrosis: A single centre preliminary report1
COVID-19 among lung cancer patients: Data from a real-life prospective French multicentric study1
Anti-mutated citrullinated vimentin antibodies are increased in IPF patients1
Drug-induced interstitial lung disease: Indictment for apixaban1
Long-acting muscarinic antagonists (LAMA) in asthma: What is the best strategy?1
Impact of the COVID-19 pandemic on lung cancer diagnosis, treatment, mortality, and survival in Belgium: A population-based study1
Potential availability of saliva-based reverse transcription-quantitative polymerase chain reaction in extensive screening for asymptomatic individuals as a business continuity strategy during the cor1
Primary spontaneous pneumothorax: French guidelines are ready for launching!1
Bronchiectasis in France: data on disease characteristics in 630 patients from the European Bronchiectasis registry (EMBARC)1
Recovery after admission with COVID-19 pneumonia – A follow-up study1
Prognostic value of the mini nutritional assessment short-form and SpO₂/FiO₂ ratio at admission for in-hospital mortality in patients with interstitial lung disease1
0.032099008560181